Home/Pipeline/First Generic CIPRO® HC

First Generic CIPRO® HC

Otic infection/inflammation

ApprovedActive

Key Facts

Indication
Otic infection/inflammation
Phase
Approved
Status
Active
Company

About Cosette Pharmaceuticals

Cosette Pharmaceuticals is a private, commercial-stage generic drug company headquartered in Cranford, New Jersey. The company leverages its fully integrated infrastructure to develop and market a diverse portfolio of generic and OTC products, with recent successes including a first-to-file generic launch with 180-day exclusivity. Its strategy centers on portfolio expansion through strategic partnerships and internal R&D, focusing on therapeutic areas like dermatology while building out contract development and manufacturing (CDMO) capabilities. Cosette emphasizes operational efficiency, supply chain reliability, and a culture of innovation to compete in the complex generic pharmaceuticals market.

View full company profile